Schieren H, Rudolph S, Finkelstein M, Coleman P, Weissmann G
Eye problems: Some people with type 2 diabetes taking Wegovy had eye problems that included cataracts, glaucoma, and damage to the retina
There have been many field-changing updates in health care since the new millennium, but it seems that none have filtered from medicine to the public with as much reach, speed or hype as glucagon-like peptide-1 (GLP-1) receptor agonist medications
How do GLP-1s help with weight loss
Compare the PlexusDx approach: see the Weight Management Protocols for semaglutide and tirzepatide with genetic context, or start upstream with the Precision Peptide Genetic Test
Comparing GLP-1 agonists to liposuction is like comparing apples to oranges